Lightwave Logic, Inc.

Lightwave Logic, Inc. develops proprietary electro-optic polymer materials, branded Perkinamine®, for use in photonic integrated circuits and optical modulators. The company is transitioning from R&D into early commercialization through material supply licenses, technology licensing, and direct material sales to customers in telecommunications and data communications.

−7 961,9 %

97,1 %

−8 576,5 %

+147,7 %

32.69

32.69

— Lightwave Logic, Inc.
%
EO polymer materials70% Proprietary Perkinamine® chromophore materials used in polymer-based photonic devices and PICs.
Licensing and royalties25% License fees and royalties tied to use of the company's materials and technology.
Technology transfer and support5% Engineering, know-how, and development support for customer integration and commercialization.

Customers are primarily photonics and semiconductor ecosystem participants that need faster, lower-power optical...

  • Telecommunications and network equipmentprimary

    Buys EO polymer materials and licensing rights to enable higher-speed, lower-power optical links.

  • Data communications and data centersprimary

    Uses the materials in modulators and PICs for high-bandwidth interconnects supporting AI and cloud traffic.

  • Foundries and device manufacturerssecondary

    Partner with the company to scale manufacturing and integrate the materials into existing production infrastructure.

  • Strategic evaluation partnerssecondary

    Assess the technology through development and evaluation programs before potential licensing or supply agreements.

The company is headquartered in the United States, but recent revenue has been generated entirely or mostly...

  • Headquartered and operated from the United States
  • Revenue in 2025 periods was disclosed as 100% international
  • Prior-year periods still included some U.S. revenue
  • Commercial relationships are tied to global telecom and photonics partners
  • U.S.-based R&D and labs support development and manufacturing readiness

The company is focusing its commercial efforts on EO polymer materials rather than external PIC or packaged-device...

01
Commercialize EO polymer materialsshort-term

Materials supply and licensing are the clearest path to recurring revenue and customer adoption.

02
Scale through foundry and partner ecosystemsmedium-term

Foundry integration can accelerate volume production without building all manufacturing internally.

03
Strengthen product readiness and credibilitymedium-term

Reliability, QA, and testing are needed to move from lab performance to commercial adoption.

The company remains pre-scale and has a long history of operating losses, so funding needs and commercialization timing...

high

Sustained operating losses

The company has not generated enough revenue to fund operations and expects losses to continue.

Scope
Accumulated deficit and ongoing cash burn
Materiality
high
high

Financing dependence

Operations and development have been funded mainly through equity issuance, which can dilute shareholders.

Scope
Future capital raises may be needed if commercialization is delayed
Materiality
high
high

Commercialization and scale-up risk

The business depends on moving from lab development to reliable manufacturing and customer adoption.

Scope
Foundry integration, QA, and device performance validation
Materiality
high
medium

Customer concentration

Management disclosed one customer accounted for 10% or more of total revenue.

Scope
Loss or delay of a key customer could reduce already limited revenue
Materiality
medium
Revenue recognition for licenses and royalties
Reported revenue can change materially even when the business is still early-stage
Stock-based compensation
Affects GAAP losses without immediate cash outflow
Patent and IP-related charges
Can distort operating expense trends in periods with IP cleanup
Lease accounting
Affects reported assets, liabilities, and operating expense timing

: 28/04/2026